Clinical Trial Update: Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT) [Phase 1, Phase 2]

View source ↗

Summary

The CIRCUIT trial evaluated a checkpoint inhibitor in combination with radiotherapy for recurrent gastric cancer in Phase 1/2. The study has completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Fukushima Medical University | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-09-19